Christiana Davis

1.1k citations

20 papers · 715 indexed · h-index 11

Oncology top 10%
Pulmonary and Respiratory Medicine top 10%
Molecular Biology
Immunology
Cancer Research

Co-authors: Corey J. Langer Charuhas Deshpande Christine Ciunci Charu Aggarwal Joshua Bauml Roger B. Cohen Jeffrey C. Thompson Evan Alley
Topics: Cancer Immunotherapy and Biomarkers (9 papers)Lung Cancer Treatments and Mutations (9 papers)Lung Cancer Diagnosis and Treatment (4 papers)
Cited by: Oncology Pulmonary and Respiratory Medicine Cancer Research
Journals: Journal of Biological Chemistry Journal of Clinical Oncology Free Radical Biology and Medicine
Partner nations: United States Canada

In The Last Decade

Christiana Davis

18 papers receiving 707 citations

Peers

Countries citing papers authored by Christiana Davis

Since Specialization

Citations

This map shows the geographic impact of Christiana Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christiana Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christiana Davis more than expected).

Fields of papers citing papers by Christiana Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christiana Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christiana Davis. The network helps show where Christiana Davis may publish in the future.

Co-authorship network of co-authors of Christiana Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Christiana Davis. A scholar is included among the top collaborators of Christiana Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christiana Davis. Christiana Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Predictive Signatures for Responses to Checkpoint Blockade in Small-Cell Lung Cancer in Second-Line Therapy Do Not Predict Responses in First-Line Patients 2024 ·Cancers ·Jeffrey C. Thompson,Caitlin M. Tilsed,Christiana Davis,(unknown),(unknown),(unknown),Michael E. Kallen,Cynthia Timmers,Corey J. Langer,Steven M. Albelda	1
2	Brief Report: Long-Term Follow-Up of Adjuvant Pembrolizumab After Locally Ablative Therapy for Oligometastatic NSCLC 2024 ·JTO Clinical and Research Reports ·(unknown),Christiana Davis,Christine Ciunci,Charu Aggarwal,Tracey L. Evans,Roger B. Cohen,Joshua Bauml,Corey J. Langer	3
3	OA06.04 Phase II Study of Pembrolizumab and Itacitinib for Patients with Metastatic NSCLC Expressing PD-L1: Long-Term Follow up 2024 ·Journal of Thoracic Oncology ·(unknown),(unknown),(unknown),(unknown),Joshua Bauml,(unknown),(unknown),(unknown),Christiana Davis,(unknown),Lova Sun,Christine Ciunci,Charu Aggarwal,Roger B. Cohen,Andy J. Minn,(unknown),Corey J. Langer	0
4	Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With Oligoprogression 2023 ·Clinical Lung Cancer ·(unknown),Nikhil Yegya‐Raman,Siqi Zhang,(unknown),Roger B. Cohen,Charu Aggarwal,Jeffrey C. Thompson,Melina E. Marmarelis,William P. Levin,Keith A. Cengel,Christine Ciunci,Aditi P. Singh,Christopher D’Avella,Christiana Davis,Corey J. Langer,Steven J. Feigenberg	7
5	Mortality risk for patients undergoing cancer treatment who acquire SARS-CoV-2: ASCO registry. 2021 ·Journal of Clinical Oncology ·Kathryn F. Mileham,Suanna S. Bruinooge,Charu Aggarwal,(unknown),Christiana Davis,(unknown),Alexander I. Spira,(unknown),David Waterhouse,(unknown),Abdul Rahman Jazieh,Ronald C. Chen,(unknown),(unknown),Richard L. Schilsky,Elizabeth Garrett‐Mayer	1
6	Changes Over Time in COVID-19 Severity and Mortality in Patients Undergoing Cancer Treatment in the United States: Initial Report From the ASCO Registry 2021 ·JCO Oncology Practice ·Kathryn F. Mileham,Suanna S. Bruinooge,Charu Aggarwal,(unknown),Christiana Davis,(unknown),Alexander I. Spira,(unknown),David Waterhouse,Susan Moore,Abdul Rahman Jazieh,Ronald C. Chen,(unknown),(unknown),Julie R. Gralow,Richard L. Schilsky,Elizabeth Garrett‐Mayer	13
7	Outcomes in Patients With Non–small-cell Lung Cancer With Brain Metastases Treated With Pembrolizumab-based Therapy 2020 ·Clinical Lung Cancer ·Lova Sun,Christiana Davis,Wei‐Ting Hwang,(unknown),(unknown),Melina E. Marmarelis,Aditi P. Singh,Abigail T. Berman,Steven J. Feigenberg,William P. Levin,Christine Ciunci,Joshua Bauml,Roger B. Cohen,Corey J. Langer,Charu Aggarwal	30
8	Gene signature of antigen processing and presentation machinery (APM) as highly predictive of response to checkpoint blockade in lung cancer and melanoma. 2020 ·Journal of Clinical Oncology ·Jeffrey C. Thompson,Christiana Davis,Wei‐Ting Hwang,Charuhas Deshpande,(unknown),Corey J. Langer,Steven Μ. Albelda	1
9	Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma 2020 ·Journal for ImmunoTherapy of Cancer ·Jeffrey C. Thompson,Christiana Davis,Charuhas Deshpande,Wei‐Ting Hwang,(unknown),Alexander C. Huang,Tara C. Mitchell,Corey J. Langer,Steven Μ. Albelda	66
10	Outcomes in patients with metastatic non-small cell lung cancer (mNSCLC) with brain metastases treated with pembrolizumab-based therapy. 2020 ·Journal of Clinical Oncology ·Lova Sun,Christiana Davis,Melina E. Marmarelis,(unknown),(unknown),Wei‐Ting Hwang,Aditi P. Singh,Abigail T. Berman,Steven J. Feigenberg,William C. Levin,Joshua Bauml,Christine Ciunci,Roger B. Cohen,Corey J. Langer,Charu Aggarwal	2
11	Gene signatures of tumor inflammation and epithelial-to-mesenchymal transition (EMT) predict responses to immune checkpoint blockade in lung cancer with high accuracy 2019 ·Lung Cancer ·Jeffrey C. Thompson,Wei‐Ting Hwang,Christiana Davis,Charuhas Deshpande,(unknown),Yashoda Rajpurohit,Vinod Krishna,(unknown),Raluca Verona,Matthew V. Lorenzi,Corey J. Langer,Steven Μ. Albelda	93
12	P1.01-63 Impact of Prior Radiation Pneumonitis on Incidence of Immunotherapy Related Pneumonitis 2019 ·Journal of Thoracic Oncology ·Melanie Wain Kier,Melina E. Marmarelis,Christiana Davis,Varsha Jain,Abigail T. Berman,Joshua Bauml,(unknown),Christine Ciunci,Charu Aggarwal,Corey J. Langer,Rachel Cohen	0
13	Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non–Small Cell Lung Cancer 2019 ·JAMA Oncology ·Joshua Bauml,Rosemarie Mick,Christine Ciunci,Charu Aggarwal,Christiana Davis,Tracey L. Evans,Charuhas Deshpande,Linda Miller,Pooja Patel,Evan Alley,(unknown),Faith Mutale,Roger B. Cohen,Corey J. Langer	217
14	OA07.01 Phase II Study of Pembrolizumab for Oligometastatic Non-Small Cell Lung Cancer (NSCLC) Following Completion of Locally Ablative Therapy (LAT) 2018 ·Journal of Thoracic Oncology ·(unknown),(unknown),Christine Ciunci,Charu Aggarwal,Christiana Davis,Tracey L. Evans,Charuhas Deshpande,Linda Miller,Prakash A. Patel,Evan Alley,(unknown),Faith Mutale,Rachel Cohen,Corey J. Langer	2
15	Influence of TP53 Mutation on Survival in Patients With Advanced EGFR-Mutant Non–Small-Cell Lung Cancer 2018 ·JCO Precision Oncology ·Charu Aggarwal,Christiana Davis,Rosemarie Mick,Jeffrey C. Thompson,(unknown),(unknown),Stephen Bagley,Peter Gabriel,Tracey L. Evans,Joshua Bauml,Christine Ciunci,Evan Alley,Jennifer J.D. Morrissette,Roger B. Cohen,Erica L. Carpenter,Corey J. Langer	64
16	Mitochondrial Complex II Prevents Hypoxic but Not Calcium- and Proapoptotic Bcl-2 Protein-induced Mitochondrial Membrane Potential Loss 2010 ·Journal of Biological Chemistry ·Brian J. Hawkins,Mark Levin,Patrick J. Doonan,Nataliya Petrenko,Christiana Davis,Vickas V. Patel,Muniswamy Madesh	37
17	Nitration of the mitochondrial complex I subunit NDUFB8 elicits RIP1- and RIP3-mediated necrosis 2009 ·Free Radical Biology and Medicine ·Christiana Davis,Brian J. Hawkins,Subbiah Ramasamy,Krishna M. Irrinki,Bruce A. Cameron,Khalid Islam,(unknown),Patrick J. Doonan,Yefim Manevich,Muniswamy Madesh	98
18	Expression of nitric oxide synthases and endogenous NO metabolism in bronchopulmonary dysplasia 2008 ·Pediatric Pulmonology ·Christiana Davis,Linda W. Gonzales,Roberta A. Ballard,Philip L. Ballard,Changjiang Guo,Andrew J. Gow	16
19	Immunohistochemical Detection of <I>S</I>-Nitrosylated Proteins 2004 ·Humana Press eBooks ·Andrew J. Gow,Christiana Davis,David Munson,Harry Ischiropoulos	17
20	Surfactant Protein-D, a Mediator of Innate Lung Immunity, Alters the Products of Nitric Oxide Metabolism 2003 ·American Journal of Respiratory Cell and Molecular Biology ·Elena N. Atochina‐Vasserman,Michael F. Beers,Samuel Hawgood,Francis R. Poulain,Christiana Davis,(unknown),Andrew J. Gow	47

About Christiana Davis

Christiana Davis is a scholar working on Oncology, Endocrine and Autonomic Systems and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 715 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (9 papers) and Lung Cancer Diagnosis and Treatment (4 papers). The work is most often cited by research in Oncology (381 citations), Pulmonary and Respiratory Medicine (357 citations) and Cancer Research (115 citations). Christiana Davis has collaborated with scholars based in United States and Canada. Frequent co-authors include Corey J. Langer, Charuhas Deshpande, Christine Ciunci, Charu Aggarwal, Joshua Bauml, Roger B. Cohen, Jeffrey C. Thompson, Evan Alley, Rosemarie Mick and Tracey L. Evans. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Free Radical Biology and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact